Earnings
Ultrapar posts Q2 2026 earnings beat on cash flow surge
Brazilian conglomerate reports higher-than-expected earnings per share and a sharp rise in operating cash flow for the quarter.
Bridgemarq Q2 2026 earnings beat forecasts, shares rise
Canadian mortgage investment firm Bridgemarq reported second-quarter 2026 results above analyst expectations, lifting its stock in after-hours trading.
Sucro Q2 2026 earnings: margins rise as revenue declines
Sucro reported margin expansion in its latest quarter despite a 6% year-over-year drop in revenue, according to its Q2 2026 earnings call.
YETI reports Q2 2026 revenue growth of 9% amid margin pressures
Outdoor gear maker YETI posts 9% revenue increase in Q2 2026 but warns higher costs are squeezing profitability. Shares seen under pressure.
Brookfield Q3 earnings: Wealth Solutions seen as key growth driver
Brookfield Asset Management's third-quarter results hinge on its wealth management arm, as investors assess its contribution to overall growth amid market volatility.
Kontoor Brands Q2 profit beats estimates, revenue lags
Apparel maker posts adjusted earnings per share above forecasts but misses revenue expectations amid weak demand.
Radcom misses earnings, revenue forecasts by wide margin
Telecom software firm Radcom reported adjusted EPS of $0.12 vs. $0.50 forecast and revenue of $24.1 million vs. $26.3 million estimate. Shares fell 10% in after-hours trading.
Trimble Q3 earnings top estimates by $0.06 per share
Revenue exceeded forecasts as the industrial technology group posts better-than-expected quarterly results. Shares rise in after-hours trading.
Protalix misses earnings by $0.07 but beats revenue forecasts
Biopharma firm Protalix reported adjusted earnings below expectations despite revenue exceeding estimates for the quarter.
Coty shares seen swinging 10% on earnings, options data
Options market signals potential 10% move in Coty stock following quarterly earnings release, with implied volatility elevated ahead of report.
Arbutus Biopharma matches earnings, tops revenue estimates
Biotech firm Arbutus Biopharma reported in-line earnings and revenue above Wall Street forecasts for the quarter. Shares were indicated higher in after-hours trading.
National Vision Q2 2026 slides show margin gains despite traffic decline
Earnings presentation highlights improved profitability but raises questions over customer footfall trends.
Venu Q2 2026 earnings miss despite pipeline growth
Venue reported second-quarter 2026 adjusted earnings per share below expectations as revenue growth failed to offset rising costs. Pipeline expansion remained strong.
National Vision tops Q2 EPS estimates but shares drop 7.2%
The optical retailer exceeded profit forecasts in its latest quarter but warned of soft demand, sending shares lower despite beating expectations.
Formycon raises H1 2026 revenue forecast, narrows losses
German biotech firm Formycon raised its revenue guidance for the first half of 2026 while reducing its net loss, citing strong demand for its ophthalmology pipeline.
Andean Precious Metals posts Q2 2026 loss, shares drop
Mineral explorer reports wider-than-expected deficit as operational costs rise and revenue lags. Stock slides on earnings miss.
Meren raises 2026 outlook after Q2 cash flow meets forecasts
Finnish energy services firm Meren raised its long-term growth targets following steady second-quarter cash flow that matched analyst expectations.
LiqTech Q2 2026 revenue misses forecast as earnings call transcript reveals shortfall
LiqTech International reported second-quarter 2026 revenue below market expectations, according to its earnings call transcript, as demand for filtration systems softened.
Apotex Q1 2026 earnings rise on semaglutide demand
Generic drugmaker Apotex reports solid quarterly growth as demand for its semaglutide products accelerates. Revenue and profit figures reflect broader trends in diabetes and weight-loss treatment markets.
Reed’s Q2 2026 earnings miss offsets margin improvement
Reed reported second-quarter 2026 results below expectations, though gross margins expanded. Analysts question outlook amid weak demand.
Legence earnings eyed as AI demand tests profit margins
Healthcare services firm faces margin scrutiny as artificial intelligence investment weighs on near-term profitability.
ReNew Energy Q1 results eyed ahead of privatization talks
Indian renewable energy firm’s quarterly earnings to be scrutinized as potential stake sale by government nears. Results due after market close on Thursday.
EnerSys earnings preview: Margin resilience tested after cost cuts
Industrial battery maker EnerSys reports Q4 results Thursday; analysts assess whether efficiency gains from restructuring can offset softer demand and input costs.
MSG Sports earnings in focus after Knicks' NBA title win
Media giant MSG Sports reports quarterly results amid record revenue boost from New York Knicks' historic championship run.